FDA grants RMAT designation to Tenaya's TN-401 heart gene therapy

Go back to FDA grants RMAT designation to Tenaya's TN-401 heart gene therapy
(NASDAQ: TNYA) Delayed: 0.68 +0.01 (1.49%)
Previous Close $0.67    52 Week High
Open $0.68    52 Week Low
Day High $0.71    P/E N/A 
Day Low $0.67    EPS
Volume 4,856,684